CURX vs NTRS · $8.9M cap vs P/E 18, rev $2.69B
Curanex Pharmaceuticals Inc Common Stock (CURX) versus Northern Trust Corporation (NTRS) — a side-by-side from cached financials, not a winner call.
Curanex Pharmaceuticals Inc Common Stock (CURX) is a biotechnology company listed on NASDAQ.
Northern Trust Corporation (NTRS) is a asset management company listed on US.
CURX does not have a complete income-statement cache yet.
Latest reported NTRS revenue for 2026-06-30 was $2.69B. Net income was $1.32B. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
CURX currently screens at market cap $8.9M. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
Not investment advice. Open the CURX and NTRS stock pages for the full models.
Not investment advice.